Bio Break: Microbes – Heroes of Medicine

Resources

Bio Break: Microbes – Heroes of Medicine

Sector: Diagnostics
Topic: Bio Break

In this episode of Bio Break, Joris and Nick explore the fascinating ways microbes and nature inspire medical innovations, showing how these tiny organisms play an outsized role in advancing healthcare and biotechnology. From lifesaving antibiotics like penicillin to revolutionary technologies like CRISPR-Cas9, they dive deep into the surprising and transformative contributions of microbes to medicine, shedding light on their critical role in shaping modern science and improving patient outcomes.

The discussion begins with Nick reflecting on how bacteria, often seen as enemies, can also be powerful allies. He highlights the production of recombinant medicines, such as insulin, using genetically modified E. coli, a groundbreaking achievement in the 1970s that paved the way for modern biopharmaceuticals.

Joris introduces the discovery of penicillin, a game-changer in combating bacterial infections, and explains how its origins lie in the natural interactions between fungi and bacteria. Found on a cantaloupe in the late 1920s, penicillin was developed into the world’s first antibiotic, saving countless lives.

The episode also dives into the incredible innovation of CRISPR-Cas9, a gene-editing tool derived from bacterial immune systems. This Nobel Prize-winning technology acts like molecular scissors, enabling precise edits to genetic material and opening new possibilities in treating genetic disorders and developing advanced therapies.

Key takeaways from the episode include:

  • How microbes are harnessed to produce essential medicines like insulin and penicillin.
  • The role of bacteriophages and CRISPR-Cas9 in advancing genetic research and treatment.
  • The importance of fundamental research in understanding nature’s mechanisms and applying them to medical device development and biopharmaceuticals.

This episode showcases the profound impact of microbial research on healthcare, highlighting how innovations inspired by nature continue to revolutionize medicine.

Whether you’re a medical device developer, biotech researcher, or healthcare professional, this episode will inspire you to see the potential of nature’s smallest organisms in solving humanity’s greatest challenges.

Microbes – Heroes of Medicine

Healthcare business and Medical examination, Doctor with icon medical with analyzing data

We all know medical devices have labels, but how often do we consider their purpose and the effort required to ensure they provide the right information? Device labelling serves as the interface between the manufacturer, the user, and regulatory bodies. (Note that being from Canada, we spell labelling with two Ls.)

Room for sterilization of medical instruments in a modern outpatient clinic

Sterilization is a critical process in the medical device industry as it provides a reliable way to ensure that devices are free from harmful microorganisms when they are used on patients. This blog talks about the categories of sterilization currently used on medical devices in manufacturing settings. It also addresses concerns surrounding the use of ethylene oxide (EtO), an indispensable method for sterilizing heat and moisture sensitive devices.

Female professional doctor showing medical test result explaining prescription using digital tablet app visiting senior woman patient at home sitting on sofa. Elderly people healthcare tech concept

Predicting the trends of a new year is always interesting and a bit unpredictable. We asked our medical device design and development professionals to submit their most interesting medtech trends for 2025 and the reasoning behind their prediction. The results were surprisingly focused on two major trends: Home Healthcare and Wearable Devices. Within these categories, several technologies were identified including edge computing, IoT, and connected devices. In no particular ranking, here are our 2025 predictions:  

Mammalogist doctor examines a woman breasts and lymph nodes during appointment. Skillful oncologist puncture of mammary glands of young patient under review ultrasound for diagnosis of breast cancer.

The U.S. Food and Drug Administration (FDA) and the Office for Human Research Protections (OHRP) have released a draft guidance document, Considerations for Including Tissue Biopsies in Clinical Trials, issued in January 2025. It provides recommendations for sponsors, investigators, institutions, and Institutional Review Boards (IRBs) on the safe and ethical incorporation of tissue biopsies in clinical trials.